Wilson Asset Management International PTY Ltd. Decreases Stock Holdings in Synopsys, Inc. $SNPS

Key Points

• Wilson Asset Management International trimmed its stake in Synopsys by 7.4%, selling 2,438 shares to hold 30,489 shares worth $14.321 million, making SNPS its 11th-largest holding (~3.7% of the fund).
• Synopsys beat estimates with quarterly EPS of $3.77 versus $3.56 expected and revenue of $2.41 billion (up 65.6% year-over-year), and issued FY2026 guidance of 14.38–14.46 EPS and Q2 guidance of 3.11–3.17 EPS.
• About 85.5% of SNPS is owned by institutional investors; analysts are mixed (consensus rating "Hold") with a consensus price target near $531 while the company carries a market cap around $96.3 billion and a P/E of ~78.

Wilson Asset Management International PTY Ltd. trimmed its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 7.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,489 shares of the semiconductor company's stock after selling 2,438 shares during the quarter. Synopsys accounts for approximately 3.7% of Wilson Asset Management International PTY Ltd.'s holdings, making the stock its 11th biggest holding. Wilson Asset Management International PTY Ltd.'s holdings in Synopsys were worth $14,321,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Sowell Financial Services LLC boosted its holdings in shares of Synopsys by 2.0% during the 4th quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company's stock valued at $496,000 after buying an additional 21 shares in the last quarter. Natural Investments LLC grew its position in Synopsys by 4.6% during the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company's stock valued at $226,000 after purchasing an additional 21 shares during the last quarter. Financial Management Professionals Inc. lifted its position in Synopsys by 7.0% in the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company's stock valued at $157,000 after acquiring an additional 22 shares in the last quarter. Foronjy Financial LLC lifted its position in Synopsys by 5.2% in the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company's stock valued at $210,000 after acquiring an additional 22 shares in the last quarter. Finally, Barden Capital Management Inc. lifted its position in Synopsys by 1.2% in the 4th quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company's stock valued at $877,000 after acquiring an additional 23 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Price Performance

Shares of Synopsys stock opened at $502.51 on Wednesday. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73. The stock's fifty day moving average is $431.32 and its 200 day moving average is $446.18. The stock has a market cap of $96.26 billion, a P/E ratio of 78.03, a P/E/G ratio of 4.06 and a beta of 1.25. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company had revenue of $2.41 billion for the quarter, compared to analysts' expectations of $2.39 billion. During the same quarter last year, the business earned $3.03 EPS. The firm's revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.3 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SNPS has been the topic of several research analyst reports. Morgan Stanley restated an "equal weight" rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Piper Sandler lowered their target price on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a research note on Thursday, February 26th. Needham & Company LLC restated a "buy" rating on shares of Synopsys in a research note on Thursday, February 26th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a "buy" rating in a report on Wednesday, February 25th. Finally, Rosenblatt Securities lowered their price target on Synopsys from $560.00 to $530.00 and set a "buy" rating on the stock in a report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Synopsys presently has an average rating of "Hold" and a consensus price target of $531.00.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.